Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital
Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 is a potentially severe and rare condition that still needs a better understanding to guide its management. Reports worldwide, and especially in Latin America, are still scarce. This report presents ten cases of pediatric inflammatory multisystem syndrome temporally associated with COVID-19 in children between 2 and 12 years old treated in a Peruvian hospital, diagnosed using the Centers for Disease Control and Prevention criteria. Severe acute respiratory syndrome coronavirus 2 was detected through serological tests (immunoglobulin M or G). Most had gastrointestinal symptoms. Therapeutics consisted mainly of intravenous immunoglobulin, corticosteroids, ivermectin, hydroxychloroquine, digoxin, and antibiotic therapy. Three patients underwent mechanical ventilation; no mortality occurred in this case series. In conclusion, the manifestations presented here are similar to those reported in the literature. A timely diagnosis is necessary for proper management..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Medwave - 21(2021), 02, Seite e8142-e8142 |
| Sprache: |
Englisch ; Spanisch |
|---|
| Beteiligte Personen: |
Consuelo Luna-Muñoz [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Child |
|---|
| doi: |
10.5867/medwave.2021.02.8142 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ016246594 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ016246594 | ||
| 003 | DE-627 | ||
| 005 | 20230310081645.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5867/medwave.2021.02.8142 |2 doi | |
| 035 | |a (DE-627)DOAJ016246594 | ||
| 035 | |a (DE-599)DOAJd9ad92bb8c724596addc2257308807eb | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Consuelo Luna-Muñoz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 is a potentially severe and rare condition that still needs a better understanding to guide its management. Reports worldwide, and especially in Latin America, are still scarce. This report presents ten cases of pediatric inflammatory multisystem syndrome temporally associated with COVID-19 in children between 2 and 12 years old treated in a Peruvian hospital, diagnosed using the Centers for Disease Control and Prevention criteria. Severe acute respiratory syndrome coronavirus 2 was detected through serological tests (immunoglobulin M or G). Most had gastrointestinal symptoms. Therapeutics consisted mainly of intravenous immunoglobulin, corticosteroids, ivermectin, hydroxychloroquine, digoxin, and antibiotic therapy. Three patients underwent mechanical ventilation; no mortality occurred in this case series. In conclusion, the manifestations presented here are similar to those reported in the literature. A timely diagnosis is necessary for proper management. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a kawasaki disease | |
| 650 | 4 | |a child | |
| 650 | 4 | |a covid-19 related pediatric multisystem inflammatory disease | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Giuliana Reyes-Florian |e verfasserin |4 aut | |
| 700 | 0 | |a Martin Seminario-Aliaga |e verfasserin |4 aut | |
| 700 | 0 | |a Angie Stapleton-Herbozo |e verfasserin |4 aut | |
| 700 | 0 | |a Lucy E. Correa-López |e verfasserin |4 aut | |
| 700 | 0 | |a Dante M. Quiñones-Laveriano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Medwave |d Medwave Estudios Limitada, 2013 |g 21(2021), 02, Seite e8142-e8142 |w (DE-627)DOAJ000046760 |x 07176384 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:02 |g pages:e8142-e8142 |
| 856 | 4 | 0 | |u https://doi.org/10.5867/medwave.2021.02.8142 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/d9ad92bb8c724596addc2257308807eb |z kostenfrei |
| 856 | 4 | 0 | |u https://www.medwave.cl/link.cgi/Medwave/Estudios/Casos/8142.act |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0717-6384 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0717-6384 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 02 |h e8142-e8142 | ||